Clincosm LogoSign in Get a demo

HIV Infections

Showing NaN - NaN of 448
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Screen to Prevent: Using Digital Health to Improve HIV Screening

Not yet recruiting
  • HIV Infections
  • Universal Opt-out HIV Screening
  • Columbus, Ohio
  • +3 more
Aug 21, 2023

HIV Trial in Puerto Rico, United States (VH3810109, Cabotegravir, Standard of care (SOC))

Not yet recruiting
  • HIV Infections
  • VH3810109
  • +3 more
  • Birmingham, Alabama
  • +42 more
Aug 9, 2023

Optimizing CAB-LA as PrEP for Women Who Inject Drugs

Recruiting
  • HIV Infections
  • +2 more
    • Philadelphia, Pennsylvania
      Prevention Point Philadelphia
    Apr 4, 2023

    People Living With HIV Treated With CD19-directed CAR T Cell

    Active, not recruiting
    • Leukemia
    • +9 more
      • Philadelphia, Pennsylvania
        Pennsylvania Hospital
      Mar 29, 2023

      HIV Trial in United States (BG505 MD39.3 mRNA, BG505 MD39.3 gp151 mRNA, BG505 MD39.3 gp151 CD4KO mRNA)

      Suspended
      • HIV Infections
      • BG505 MD39.3 mRNA
      • +2 more
      • Birmingham, Alabama
      • +9 more
      Feb 1, 2023

      HIV Trial in Philadelphia (3BNC117-LS, 10-1074-LS)

      Suspended
      • HIV Infections
      • Birmingham, Alabama
      • +5 more
      Jan 31, 2023

      Hepatitis B, HIV Trial in Worldwide (Selgantolimod, Placebo)

      Recruiting
      • Hepatitis B
      • HIV Infections
      • San Diego, California
      • +35 more
      Jan 31, 2023

      HIV Trial in United States (PGT121.414.LS, VRC07-523LS)

      Completed
      • HIV Infections
      • PGT121.414.LS
      • VRC07-523LS
      • Los Angeles, California
      • +4 more
      Jan 31, 2023

      HIV Trial in Worldwide (Cabotegravir Tablets, Cabotegravir Injectable Suspension (CAB LA), Rilpivirine Tablets)

      Active, not recruiting
      • HIV Infections
      • Cabotegravir Tablets
      • +4 more
      • Bakersfield, California
      • +116 more
      Jan 22, 2023

      HIV, HIV-1 Trial in Worldwide (Etravirine)

      Active, not recruiting
      Has Results
      • HIV Infections
      • HIV-1
      • Los Angeles, California
      • +30 more
      Jan 17, 2023

      Consent for Use of Stored Patient Specimens for Future Testing

      Recruiting
      • HIV Infections
        • Los Angeles, California
        • +62 more
        Dec 7, 2022

        HIV Trial in United States (APRETUDE, Cabotegravir OLI)

        Recruiting
        • HIV Infections
        • Los Angeles, California
        • +16 more
        Oct 24, 2022

        HIV Trial in Miami, Detroit, Philadelphia (Clinic-based Delivery, Remote Delivery, Multi-modal Delivery)

        Completed
        • HIV Infections
        • Clinic-based Delivery
        • +2 more
        • Miami, Florida
        • +2 more
        Sep 6, 2022

        HIV, Drug Use, Opioid Use Trial in United States (drug, diagnostic test, other, behavioral)

        Enrolling by invitation
        • HIV Infections
        • +3 more
        • Medication for opioid-use disorder (MOUD) for opioid-use disorder (OUD)
        • +10 more
        • Los Angeles, California
        • +4 more
        Aug 30, 2022

        Antiretroviral Drugs and Related Drugs During and After

        Completed
        Has Results
        • HIV Infections
        • Birmingham, Alabama
        • +61 more
        Jun 28, 2022

        HIV Trial in Worldwide (DTG + 3TC, TAF based regimen (TBR))

        Completed
        Has Results
        • HIV Infections
        • DTG + 3TC
        • TAF based regimen (TBR)
        • Phoenix, Arizona
        • +132 more
        Jun 27, 2022

        Cannabis, HIV and Mental Processing Systems

        Enrolling by invitation
        • HIV Infections
        • Cannabis
        • MRI
        • +4 more
        • Saint Louis, Missouri
        • +1 more
        Jun 23, 2022

        Cytomegalovirus Infections, HIV, Vaccine Trial in United States (CMV-MVA Triplex, Placebo)

        Recruiting
        • Cytomegalovirus Infections
        • +2 more
        • CMV-MVA Triplex
        • Placebo
        • Birmingham, Alabama
        • +11 more
        Jun 20, 2022

        HIV, Cytomegalovirus, CMV Trial in United States (Letermovir 240 MG Oral Tablet, Letermovir 480 MG Oral Tablet, Combination ART)

        Recruiting
        • HIV Infections
        • +2 more
        • Letermovir 240 MG Oral Tablet
        • +2 more
        • Birmingham, Alabama
        • +18 more
        Jun 20, 2022

        HIV Trial in Worldwide (Placebo for maraviroc (MVC), Placebo for dolutegravir (DTG), Dolutegravir (DTG))

        Completed
        Has Results
        • HIV Infections
        • Placebo for maraviroc (MVC)
        • +3 more
        • Los Angeles, California
        • +29 more
        Apr 20, 2022

        Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (GSK1349572, Raltegravir, GSK1349572 Placebo)

        Completed
        Has Results
        • Infection, Human Immunodeficiency Virus
        • HIV Infections
        • Birmingham, Alabama
        • +180 more
        Mar 14, 2022

        HIV Trial in United States (Doravirine 100 Mg, Tenofovir alafenamide/emtricitabine, tenofovir alafenamide/lamivudine)

        Recruiting
        • HIV Infections
        • Doravirine 100 Mg
        • +5 more
        • Birmingham, Alabama
        • +22 more
        Feb 22, 2022

        HIV Trial in Worldwide (VRC01, Placebo for VRC01)

        Completed
        Has Results
        • HIV Infections
        • VRC01
        • Placebo for VRC01
        • Birmingham, Alabama
        • +25 more
        Feb 8, 2022

        Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (Dolutegravir/abacavir/lamivudine FDC, Atazanavir, Ritonavir)

        Active, not recruiting
        Has Results
        • Infection, Human Immunodeficiency Virus
        • HIV Infections
        • Dolutegravir/abacavir/lamivudine FDC
        • +3 more
        • Phoenix, Arizona
        • +88 more
        Feb 8, 2022

        HIV, Sexually Transmitted Diseases, Stigma, Social Trial in Chapel Hill, Durham, Philadelphia (Information Resources, Social

        Recruiting
        • HIV Infections
        • +2 more
        • Information Resources
        • +2 more
        • Chapel Hill, North Carolina
        • +2 more
        Jan 19, 2022